FDA-approved (Zadaxin) for hepatitis with potent immune-modulating properties. Used for immune enhancement, viral recovery, and oncology adjunct.
Pre-filled with standard Thymosin α1 values. Adjust as needed.
Standard: 1.6mg subcutaneously 2x weekly. Acute protocol: 1.6mg daily for 7–14 days. Used in integrative oncology and post-COVID immune restoration.
Blood markers to track
Note: FDA-approved as Zadaxin. Strong immune evidence. Used in integrative oncology and post-viral protocols.
Log CD4/CD8 T-cell count and NK cell activity across draws and let StackAI analyze your response. Free to start.
Track my Thymosin α1 labs free →